论文部分内容阅读
目的:观察肾宝口服液联合激素治疗IgA肾病肾病综合征的疗效。方法:64例IgA肾病肾病综合征患者分为观察组及对照组,对照组给予激素常规治疗,观察组在对照组基础上加用中药肾宝口服液,治疗后12个月监测生化指标,评价疗效。结果:观察组降低尿蛋白、升高血清白蛋白效果明显优于对照组(P<0.05),不良反应发生率两组差异无统计学意义(P>0.05)。结论:肾宝口服液联合激素治疗IgA肾病肾病综合征可明显缓解症状,降低尿蛋白及升高血清白蛋白方面明显优于单用激素治疗,且不良反应发生率低。
Objective: To observe the effect of Shenbao Oral Liquid Combined with Hormone on IgA nephropathy nephrotic syndrome. Methods: Sixty-four patients with IgA nephrotic syndrome were divided into observation group and control group. The control group was given routine treatment with hormone. The observation group was treated with Shenbao oral liquid on the basis of the control group. The biochemical indexes were monitored 12 months after treatment. Efficacy. Results: The observation group was significantly lower than the control group in reducing urine protein and serum albumin (P <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion: Shenbao oral solution combined with hormonal treatment of IgA nephropathy nephrotic syndrome can significantly relieve symptoms, reduce urinary protein and raise serum albumin was significantly better than single hormone therapy, and the incidence of adverse reactions is low.